In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI),
gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …

Magnetic particle imaging (MPI) is a novel imaging method that was first proposed by Gleich
and Weizenecker in 2005. Applying static and dynamic magnetic fields, MPI exploits the …

1.1. Purpose The European Society for Vascular Surgery (ESVS) appointed the Descending
Thoracic Aorta (DTA) Writing Committee (WC) to produce the current clinical practice …

Importance Risk of nephrogenic systemic fibrosis (NSF) to individual patients with stage 4 or
5 chronic kidney disease (CKD; defined as estimated glomerular filtration rate of< 30 …

Purpose To assess whether an association exists between hyperintensity in the dentate
nucleus (DN) on unenhanced T1-weighted magnetic resonance (MR) images and previous …

Purpose of review: Use of gadolinium-based contrast agents (GBCA) in renal impairment is
controversial, with physician and patient apprehension in acute kidney injury (AKI), chronic …

Thirty years ago, Schering filed the first patent application for a contrast agent for magnetic
resonance imaging (MRI) covering the forefather of the gadolinium contrast agents and still …

Purpose To compare the diagnostic accuracy of contrast‐enhanced (CE) magnetic
resonance imaging (MRI) and diffusion‐weighted MRI (DWI) in the differentiation between …

Intravenous (IV) contrast material is used extensively for CT and MRI scans done in
emergency departments (ED). Its use is essential to make many critical diagnoses in ED …

Gadolinium-based contrast agents (GBCAs) increase lesion detection and improve disease
characterization for many cerebral pathologies investigated with MRI. These agents …